Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives

被引:382
作者
Ugwoke, MI
Agu, RU
Verbeke, N
Kinget, R
机构
[1] OctoPlus Dev BV, NL-2333 CL Leiden, Netherlands
[2] Katholieke Univ Leuven, Lab Farmacotechnol Biofarm, B-3000 Louvain, Belgium
[3] Dalhousie Univ, Coll Pharm, Halifax, NS B3H 3J5, Canada
关键词
absorption enhancer; microparticles; microspheres; mucoadhesion; mucociliary clearance; nasal absorption; nasal drug delivery; polymer;
D O I
10.1016/j.addr.2005.07.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nasal drug delivery has now been recognized as a very promising route for delivery of therapeutic compounds including biopharmacuticals. It has been demonstrated that low absorption of drugs can be countered by using absorption enhancers or increasing the drug residence time in the nasal cavity, and that some mucoadhesive polymers can serve both functions. This article reviews the background of nasal mucoadhesive drug delivery with special references to the biological and pharmaceutical considerations for nasal mucoadhesive drug administration. Applications of nasal mucoadhesives for the delivery of small organic molecules, antibiotics, proteins, vaccines and DNA are also discussed. Furthermore, new classes of functionalized mucoadhesive polymers, the characterization and safety aspects of nasal drug products as well as the opportunities presented by nasal drug delivery are extensively discussed. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:1640 / 1665
页数:26
相关论文
共 161 条
[1]   Evaluation of the mucosal irritation potency of co-spray dried Amioca®/poly (acrylic acid) and Amioca®/Carbopol® 974P mixtures [J].
Adriaens, E ;
Ameye, D ;
Dhondt, MMM ;
Foreman, P ;
Remon, JP .
JOURNAL OF CONTROLLED RELEASE, 2003, 88 (03) :393-399
[2]   Mechanistic appraisal of the effects of some protease inhibitors on ciliary beat frequency in a sequential cell culture system of human nasal epithelium [J].
Agu, RU ;
Jorissen, M ;
Willems, T ;
Kinget, R ;
Verbeke, N .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2003, 55 (03) :283-289
[3]   Nasal absorption enhancement strategies for therapeutic peptides: an in vitro study using cultured human nasal epithelium [J].
Agu, RU ;
Dang, HV ;
Jorissen, M ;
Willems, T ;
Kinget, R ;
Verbeke, N .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 237 (1-2) :179-191
[4]  
Agu RU, 2002, STP PHARMA SCI, V12, P13
[5]  
Agu RU, 1999, PHARMACEUT RES, V16, P1380
[6]   Intranasal vaccination against plague, tetanus and diphtheria [J].
Alpar, HO ;
Eyles, JE ;
Williamson, ED ;
Somavarapu, S .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 51 (1-3) :173-201
[7]   Permeability issues in nasal drug delivery [J].
Arora, P ;
Sharma, S ;
Garg, S .
DRUG DISCOVERY TODAY, 2002, 7 (18) :967-975
[8]   Chitosan as a nasal delivery system: The effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers [J].
Aspden, TJ ;
Mason, JDT ;
Jones, NS ;
Lowe, J ;
Skaugrud, O ;
Illum, L .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (04) :509-513
[9]  
BANWELL JG, 1983, GASTROENTEROLOGY, V84, P506
[10]   Effects of physicochemical properties and other factors on systemic nasal drug delivery [J].
Behl, CR ;
Pimplaskar, HK ;
Sileno, AP ;
deMeireles, J ;
Romeo, VD .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 29 (1-2) :89-116